Price Chart

Profile

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
URL https://www.proqr.com
Investor Relations URL https://www.proqr.com/investors-and-media
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Nov. 07, 2024 (est.)
Last Earnings Release Aug. 08, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
URL https://www.proqr.com
Investor Relations URL https://www.proqr.com/investors-and-media
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Nov. 07, 2024 (est.)
Last Earnings Release Aug. 08, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A